Dividend Stock of the Week: BAE Systems Leaps on War Risk

BAE Systems' full-year results for 2024 have beat analyst expectations as European governments up defence spending.

Christopher Johnson 21 February, 2025 | 9:29AM
Facebook Twitter LinkedIn

 

 

Christopher Johnson: European governments are upping their defence spend amid increased geopolitical tension, and defence valuations have shot up in response.

In the UK all eyes are on dividend aristocrat BAE Systems after it released its full year results for 2024, which shows it has benefited from increased military spending. The company’s underlying earnings rose by 14% to over £3 billion, with revenues totalling £26.3 billion.

BAE Systems won a total of £33.7 billion worth of orders in 2024 increasing its backlog to a record £78 billion due to strong government demand. Orders were driven by a range of contract wins, from warships for Australia, to deliveries of its pan-European Eurofighter Typhoon aircraft in Spain and Italy.

So, should income seekers add BAE Systems to their portfolios?

The aerospace and defence company is currently yielding over 2%. Its final dividend for 2024 is 20.6p and will be paid on June 2nd, 2025.

Altogether, its total dividend for 2024 is 33p, a substantial increase from the 30p paid in 2023 and the 27p paid in 2022. BAE Systems is up over 14% so far this year, and is trading at £13.24 pence per share.

Morningstar analyst Loredana Muharremi who covers the stock views BAE Systems as undervalued, with the stocks share price sitting below Morningstar’s Fair Value Estimate of £15.50.

Read Morningstar’s Industry Defense Landscape for more information on the global defense sector.


The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

TAGS

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Christopher Johnson  is data journalist at Morningstar

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures